Abstract: Novel pharamaceutical sustained release composition comprising at least one active agent(s), or its tautomeric forms, analogues, isomers, polymorphs, sovates, or salts thereof; preferably an antiviral active agent is provided. Also provided is a process of preparation of such composition and method of using them. The sustained release compositions of the present invention are able to deliver the active agent in a desired manner for an extended period of time.
| # | Name | Date |
|---|---|---|
| 1 | 1680-del-2005-abstract.pdf | 2011-08-21 |
| 1 | 1680-del-2005-form-5.pdf | 2011-08-21 |
| 2 | 1680-del-2005-claims.pdf | 2011-08-21 |
| 2 | 1680-del-2005-form-3.pdf | 2011-08-21 |
| 3 | 1680-del-2005-correspondence-others.pdf | 2011-08-21 |
| 3 | 1680-del-2005-form-2.pdf | 2011-08-21 |
| 4 | 1680-del-2005-description (complete).pdf | 2011-08-21 |
| 4 | 1680-del-2005-form-1.pdf | 2011-08-21 |
| 5 | 1680-del-2005-description (provisiona).pdf | 2011-08-21 |
| 6 | 1680-del-2005-description (complete).pdf | 2011-08-21 |
| 6 | 1680-del-2005-form-1.pdf | 2011-08-21 |
| 7 | 1680-del-2005-correspondence-others.pdf | 2011-08-21 |
| 7 | 1680-del-2005-form-2.pdf | 2011-08-21 |
| 8 | 1680-del-2005-claims.pdf | 2011-08-21 |
| 8 | 1680-del-2005-form-3.pdf | 2011-08-21 |
| 9 | 1680-del-2005-abstract.pdf | 2011-08-21 |
| 9 | 1680-del-2005-form-5.pdf | 2011-08-21 |